Tom Lin
Tracked across 1 events · 9 articles · First seen Jun 13, 2026 · Last active Jun 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: As Chairman and CEO of Belite Bio, Tom Lin expressed gratitude for the NDA submission milestone and emphasized the company's commitment to working with the United States — Food and Drug Administration to advance tinlarebant through the regulatory review process.
Jun 13, 2026 · 9 articles
ERGEN INTELLIGENCE
Track Tom Lin live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard